Inside a high intensity robotics laboratory in Beijing, engineers are subjecting humanoid robots to rigorous endurance testing as China accelerates efforts to bring advanced robotics into real world environments. The facility operated by X Humanoid focuses on preparing machines for unpredictable human settings,
China’s Unitree Robotics has moved forward with plans for an initial public offering on Shanghai’s Star Market, aiming to raise about 4.2 billion yuan as interest grows around humanoid robotics and embodied artificial intelligence. The listing is being closely watched by investors and
A prominent life scientist with deep ties to US research institutions has shifted his academic base to China, highlighting a growing trend of talent movement in global science. Shu Xiaokun, known for his work in advanced biological imaging and molecular tools, has returned
Major international pharmaceutical companies are accelerating their expansion in China, signaling a strategic shift toward localized production as global supply chains become more fragmented. AstraZeneca has announced plans to establish new drug manufacturing facilities in Guangzhou and Shanghai, alongside a dedicated innovation centre
China’s robotics sector is entering a new phase as Unitree Robotics moves toward a major public listing, aiming to raise around 4.2 billion yuan or roughly 610 million dollars on Shanghai’s Star Market. The Hangzhou based company has quickly emerged as one of
China’s rapid progress in robotics has captured global attention, with advanced humanoid machines taking centre stage in high profile events and demonstrations. Performances featuring coordinated movements and complex routines have highlighted the country’s growing capabilities in embodied intelligence, where artificial intelligence is integrated
Growing reliance on China’s pharmaceutical supply chain is raising concerns among US policymakers, who warn that dependence on foreign sources for critical drug ingredients could pose long term risks to healthcare security. Lawmakers are increasingly focused on how China has expanded its role
AstraZeneca is deepening its presence in China’s fast growing biotech sector with plans to build a new cell therapy facility in Shanghai, reinforcing its long term commitment to advanced medical innovation in the region. The investment forms part of a broader expansion strategy
China’s manufacturing sector is advancing into a more automation driven phase in 2026 as industrial robotics density continues to rise across key production hubs. The growing number of robots deployed per worker reflects a structural shift toward intelligent manufacturing systems that prioritize efficiency,
China’s contract drug manufacturing industry is facing growing uncertainty as United States pharmaceutical companies accelerate efforts to bring production back onshore and restructure global supply chains. The shift reflects broader geopolitical tensions and strategic concerns around dependency on overseas manufacturing, particularly in critical
